Further support for MYCN driven p53-dependent apoptosis being an important mechanism for tumor suppression in neuroblastoma comes from in vivo work using p53 or Mdm2 haploinsufficient models of neuroblastoma. This evidence concerns the gene TP53 and neoplasm.